Floatz logo

Valaciclovir

Urge Incontinence

Buddhist Tzu Chi General HospitalSmall moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Urge Incontinence cohort.

Asset / SponsorPhaseRating
Mirabegron
VA Office of Research and Development
Phase 4BB
TROSPIUM
Allergan
Phase 4BB
Nabiximols
Jazz Pharmaceuticals
Phase 3BB
Oxybutynin
University of California, Davis
Phase 3B
SOLIFENACIN
VA Office of Research and Development
Phase 4B

View all 22 →

Same molecule, other indications

Valaciclovir is also rated in:

herpes simplex infectious diseaseDormant
BBB
Indicative ·
74 / 100
View asset →
schizoaffective disorderDormant
BB
Indicative ·
68 / 100
View asset →
non-small cell lung carcinomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →